MicroRNAs in cardiovascular disease.
Atherosclerosis
Biomarkers
Cardiovascular disease
MicroRNAs
Molecular cardiology
Journal
Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
ISSN: 2241-5955
Titre abrégé: Hellenic J Cardiol
Pays: Netherlands
ID NLM: 101257381
Informations de publication
Date de publication:
Historique:
received:
09
12
2019
revised:
08
03
2020
accepted:
19
03
2020
pubmed:
20
4
2020
medline:
19
8
2021
entrez:
20
4
2020
Statut:
ppublish
Résumé
Cardiovascular disease (CVD) remains the predominant cause of human morbidity and mortality in developed countries. Currently, microRNAs have been investigated in many diseases as well-promising biomarkers for diagnosis, prognosis, and disease monitoring. Plenty studies have been designed so as to elucidate the properties of microRNAs in the classification and risk stratification of patients with CVD and also to evaluate their potentials in individualized management and guide treatment decisions. Therefore, in this review article, we aimed to present the most recent data concerning the role of microRNAs as potential novel biomarkers for cardiovascular disease.
Identifiants
pubmed: 32305497
pii: S1109-9666(20)30067-1
doi: 10.1016/j.hjc.2020.03.003
pii:
doi:
Substances chimiques
Biomarkers
0
MicroRNAs
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
165-173Informations de copyright
Copyright © 2020 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.